These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 24094372)

  • 21. Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.
    Rakheja R; Makis W; Skamene S; Nahal A; Brimo F; Azoulay L; Assayag J; Turcotte R; Hickeson M
    AJR Am J Roentgenol; 2012 Jun; 198(6):1409-16. PubMed ID: 22623556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG PET/CT of transitional cell carcinoma.
    Patil VV; Wang ZJ; Sollitto RA; Chuang KW; Konety BR; Hawkins RA; Coakley FV
    AJR Am J Roentgenol; 2009 Dec; 193(6):W497-504. PubMed ID: 19933624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
    Dimitrakopoulou-Strauss A; Strauss LG; Schwarzbach M; Burger C; Heichel T; Willeke F; Mechtersheimer G; Lehnert T
    J Nucl Med; 2001 May; 42(5):713-20. PubMed ID: 11337565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDG PET/CT findings in rare sarcomas.
    Ergül N; Aydın M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):324-7. PubMed ID: 23352751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.
    Lim HJ; Johnny Ong CA; Tan JW; Ching Teo MC
    Crit Rev Oncol Hematol; 2019 Nov; 143():1-13. PubMed ID: 31449981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging.
    Alcorn KM; Deans KJ; Congeni A; Sulkowski JP; Bagatell R; Mattei P; Minneci PC
    J Pediatr Surg; 2013 Sep; 48(9):1903-6. PubMed ID: 24074665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular imaging of sarcomas with FDG PET.
    Mendoza H; Nosov A; Pandit-Taskar N
    Skeletal Radiol; 2023 Mar; 52(3):461-475. PubMed ID: 36173459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic Malignant Fibrous Histiocytoma Infiltrating Sigmoid Colon: A Case Diagnosed With the Help of 18F-FDG PET/CT.
    Wei WJ; Shen CT; Song HJ; Qiu ZL; Luo QY
    Clin Nucl Med; 2016 Apr; 41(4):338-40. PubMed ID: 26673233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
    Walter F; Czernin J; Hall T; Allen-Auerbach M; Walter MA; Dunkelmann S; Federman N
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):131-6. PubMed ID: 22134608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
    Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
    Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG PET/CT for bone and soft-tissue biopsy.
    Nanni C; Gasbarrini A; Cappelli A; Sandler I; Graziani T; Guidalotti P; Golfieri R; Boriani S; Fanti S
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1333-4. PubMed ID: 25693761
    [No Abstract]   [Full Text] [Related]  

  • 32. Contemporary imaging in sarcoma.
    Landa J; Schwartz LH
    Oncologist; 2009 Oct; 14(10):1021-38. PubMed ID: 19789392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
    Sharma P; Kumar R; Singh H; Jeph S; Sharma JB; Jain SK; Sharma DN; Bal C; Malhotra A
    Nucl Med Commun; 2012 Feb; 33(2):185-90. PubMed ID: 22107993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy.
    Samim M; El-Haddad GE; Molenaar IQ; Prevoo W; van den Bosch MA; Alavi A; Lam MG
    PET Clin; 2014 Oct; 9(4):469-95, vi. PubMed ID: 26050948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of positron emission tomography in the management of patients with sarcoma.
    Benz MR; Tchekmedyian N; Eilber FC; Federman N; Czernin J; Tap WD
    Curr Opin Oncol; 2009 Jul; 21(4):345-51. PubMed ID: 19412096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
    Anthony MP; Khong PL; Zhang J
    AJR Am J Roentgenol; 2009 Dec; 193(6):W523-9. PubMed ID: 19933627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
    el-Zeftawy H; Heiba SI; Jana S; Rosen G; Salem S; Santiago JF; Abdel-Dayem HM
    Cancer Biother Radiopharm; 2001 Feb; 16(1):37-46. PubMed ID: 11279796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
    Le BB; Nguyen BD
    Clin Nucl Med; 2015 Jan; 40(1):e68-70. PubMed ID: 24830875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.